Citation Impact

Citing Papers

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Inadequate erythropoietin response to anemia: definition and clinical relevance
1994
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
2018 Standout
The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation
2018 StandoutNobel
An internet survey of 2,596 people with fibromyalgia
2007 Standout
High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study
2013
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
2006 Standout
Thoracic aortic aneurysm and rupture in giant cell arteritis. a descriptive study of 41 cases
1994
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease
2016
Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis
1997
Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis
2006
Polymyalgia rheumatica and giant-cell arteritis
2008
The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations
1999
EPIDEMIOLOGY OF THE VASCULITIDES
2001
Ischemic optic neuropathy
2008 Standout
Juvenile idiopathic arthritis
2007 Standout
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period
2001
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Hla–drb1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis
1994
Apilimod Inhibits the Production of IL-12 and IL-23 and Reduces Dendritic Cell Infiltration in Psoriasis
2012
Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial
1999 Standout
Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis
1996
Distal extremity swelling with pitting edema in polymyalgia rheumatica. Report of nineteen cases
1996
Stroke associated with giant cell arteritis: a population-based study
2014
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005 Standout
Psoriasis
2021 Standout
Five Years of GWAS Discovery
2012 Standout
Psoriasis: Which therapy for which patient
2018
Genome-wide studies of psoriasis susceptibility loci: a review
2004
Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis
2011
Giant Cell Arteritis
1994
Progress in the genetics of ankylosing spondylitis
2011
Polymyalgia rheumatica
1997
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
2012 Standout
Psoriasis
2015 Standout
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
1998 Standout
Cyclosporin
1993
Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis
2009
Ankylosing spondylitis
2007 Standout
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
2012
Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis
2005
Characterization of Prostaglandin H Synthase 2 Deficient Mice and Implications for Mechanisms of NSAID Action
1997 StandoutNobel
Novel erythropoiesis stimulating protein (darbepoetin alfa) alleviates anemia associated with chronic inflammatory disease in a rodent model
2001
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
2007 Standout
Giant cell arteritis in Iceland.
1994
TAXI/UAS: A Molecular Switch to Control Expression of Genes In Vivo
1996 StandoutNobel
Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
2003 Standout
Pathogenesis of giant cell arteritis
1993
Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty‐year period
2004
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity
1999
Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment
1996
Radiography in the assessment of musculoskeletal conditions
2003
Epidemiology of polymyalgia rheumatica in olmsted county, minnesota, 1970–1991
1995
Incidence and predictors of large‐artery complication (aortic aneurysm, aortic dissection, and/or large‐artery stenosis) in patients with giant cell arteritis: A population‐based study over 50 years
2003 Standout
Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis
2009
Anemia of Chronic Disease
2005 Standout
THE RISKS AND COSTS OF UPPER GASTROINTESTINAL DISEASE ATTRIBUTABLE TO NSAIDS
1996
The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria?
2005 Standout
PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugs
1993
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
NSAID Gastropathy
1996
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
2007
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors
1998
Polymyalgia Rheumatica and Giant Cell Arteritis
1978
Operational definitions and observer reliability of the plain radiographic features of psoriatic arthritis.
2003
Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis
1996
Cyclooxygenase in biology and disease
1998 Standout
Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study.
2006
Incidence of Giant Cell Arteritis and Characteristics of Patients: Data‐Driven Analysis of Comorbidities
2014
Is Duplex Ultrasonography Useful for the Diagnosis of Giant-Cell Arteritis?
2002
Use of Recombinant Human Erythropoietin Outside the Setting of Uremia
1997
Burden of major musculoskeletal conditions.
2003 Standout
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
2012 StandoutNobel

Works of F Rossi being referenced

Prevalence of psoriatic arthritis in Italian psoriatic patients.
1995
Low dose cyclosporine A in psoriatic arthritis: relation between soluble interleukin 2 receptors and response to therapy.
1992
Elevated soluble intercellular adhesion molecule 1 in the serum of patients with polymyalgia rheumatica: influence of steroid treatment.
1994
Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy
1991
Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease.
1991
Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
1992
Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy.
1988
Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
1994
Immunologic effects in patients with psoriatic arthritis treated with cyclosporine A.
1992
The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study.
1992
Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
1995
Rankless by CCL
2026